Skip to content

Ambient Temperature and Thermoregulation During Exercise in Children and Youth

Ambient Temperature and Thermoregulation During Moderate-Intensity Exercise in Children and Youth

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07781605
Enrollment
12
Registered
2026-08-24
Start date
2026-07-19
Completion date
2027-06-30
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Temperature Changes, Child Development, Heat, Heat Stress, Physiological Stress

Keywords

Thermoregulation, Heat loss, Heat tolerance, Heat strain, Physical activity

Brief summary

Little is known about how children and youth regulate body temperature during exercise across different environmental temperatures compared with young adults, including whether differences in whole-body heat exchange contribute to their responses. The goal of this clinical trial is to determine how ambient temperature affects thermoregulation during exercise in boys and girls aged 9-16 years compared with young adult men and women aged 20-25 years. Participants will complete four study visits at ambient temperatures of 22°C (Celsius; 72°F, Fahrenheit), 26°C (79°F), 31°C (88°F), and 36°C (97°F), while exercising at the same moderate-intensity metabolic heat production of 160 W/m² (W = watts, m = meters). During each visit, participants will complete four 15-minute periods of exercise (exercise bouts 1, 2, 3 and 4 respectively) separated by 15-minute rest periods. Testing will be performed in a whole-body air calorimeter, a specialized chamber that precisely measures heat lost through evaporation and dry heat exchange and the amount of heat stored in the body. These measurements, together with core temperature and heart rate, will allow researchers to determine how increasing ambient temperature affects the body's ability to lose heat and whether these responses differ between children and youth and young adults.

Interventions

OTHERExercise at 22°C

Participants complete intermittent exercise at a metabolic heat production of 160 W/m² in an ambient temperature of 22°C (72°F).

OTHERExercise at 26°C

Participants complete intermittent exercise at a metabolic heat production of 160 W/m² in an ambient temperature of 26°C (79°F).

OTHERExercise at 31°C

Participants complete intermittent exercise at a metabolic heat production of 160 W/m² in an ambient temperature of 31°C (88°F).

OTHERExercise at 36°C

Participants complete intermittent exercise at a metabolic heat production of 160 W/m² in an ambient temperature of 36°C (97°F).

Sponsors

University of Ottawa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male or female. * Aged 9-16 years or 20-25 years. * Habitually active, defined as participating in regular physical activity at least 3 times per week for at least 20 minutes per session over the previous 6 months. * Able to understand and communicate in English or French. * For participants younger than 18 years, written parental or guardian consent and participant assent are required.

Exclusion criteria

* Acute illness at the time of testing (e.g., cold, flu, or infection). * History of a chronic medical condition that may affect thermoregulation, cardiovascular function, or exercise capacity (e.g., cardiovascular disease, metabolic disorders, respiratory disease including asthma requiring regular medication, or neurological disorders). * Use of medications known to affect thermoregulation, hydration status, or cardiovascular responses. * History of heat-related illness (e.g., heat exhaustion or heat stroke). * Digestive abnormalities or gastrointestinal conditions that may contraindicate ingestion of a telemetry pill. * Any condition that, in the opinion of the investigators, would compromise participant safety or the integrity of the data.

Design outcomes

Primary

MeasureTime frameDescription
Core temperatureEnd of each of the four 15 minutes exercise bouts (average of last 5 minutes)Core temperature indexed by visceral (telemetry pill) temperature

Secondary

MeasureTime frameDescription
Evaporative heat lossEnd of each of the four 15 minutes exercise bouts (average of last 5 minutes)Evaporative heat loss as assessed using a direct air calorimeter
Dry heat lossEnd of each of the four 15 minutes exercise bouts (average of last 5 minutes)Dry heat loss as assessed using a direct air calorimeter
Whole-body total heat lossEnd of each of the four 15 minutes exercise bouts (average of last 5 minutes)Total heat loss (evaporative + dry) as assessed using a direct air calorimeter
Body heat storageChange from start to end of exercise for each of the four 15 minutes exercise boutsHeat stored in the body for each of the exercise bouts
Skin temperatureEnd of each of the four 15 minutes exercise bouts (average of last 5 minutes)Skin temperature measured at 8-sites (forehead, chest, scapula, upper arm, forearm, hand, thigh, calf) with mean value calculated as weighted values of 8 sites - forehead 7%, chest 17.5%, scapula 17.5%, upper arm 7%, forearm 7%, hand 5%, thigh 19%, and calf 20%.
Change in skin temperatureEnd of each of the four 15 minutes exercise bouts (average of last 5 minutes)Skin temperature measured at 8-sites (forehead, chest, scapula, upper arm, forearm, hand, thigh, calf) with mean value calculated as weighted values of 8 sites - forehead 7%, chest 17.5%, scapula 17.5%, upper arm 7%, forearm 7%, hand 5%, thigh 19%, and calf 20%.
Heart rateEnd of each of the four 15 minutes exercise bouts (average of last 5 minutes)Heart rate measured continuously with chest-band telemetric device
Thermal sensationEnd of each of the four 15 minutes exercise bouts (average of last 5 minutes)Thermal sensation will be assessed using the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) 7-point scale ("0=neutral to 7=extremely hot")

Countries

Canada

Contacts

CONTACTGlen P Kenny, PhD
gkenny@uottawa.ca6135625800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 25, 2026